| Code | 6761E | ||||||||||
| MA number | 29/0136/24-S | ||||||||||
| Product Form: | gel 1x180 g (tuba Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Dr. Max Pharma s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | tube Al | ||||||||||
| Route of admin.: | Cutaneous use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 25.07.2024 |
| Validity: | 25.07.2029 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_DICLOFENAC Dr. Max 20 mg-g gél_08.2024.pdf
|
| PIL: |
PIL_DICLOFENAC Dr. Max 20 mg-g gél_08.2024.pdf
|
| Safety feature | No |
| Data update: | 30.07.2024 |
